Woodmac: Medco-Ophir merger to create SE Asia upstream powerhouse
Following this week’s announcement by Ophir Energy that the company is in talks with Medco Energi over a potential sale to the Indonesian firm, energy intelligence group Wood Mackenzie has described Medco’s swoop for Ophir as a bold one, and a move that would if completed, create an upstream powerhouse in Southeast Asia
Here is what Wood Mackenzie’s research director Angus Rodger had to say about the potential merger.
“On the first day of 2019, Ophir announced it was in talks with Indonesia’s Medco Energi regarding a cash takeover. No amount or other details have yet been released, other than Medco has to make a clear binding offer by the 28th of January if a deal is to proceed. Ophir’s upstream portfolio includes assets in Thailand, Vietnam, Indonesia, Malaysia, Equatorial Guinea and Tanzania. It also has exploration acreage in Mexico and Bangladesh.
“This is a bold move by Medco, and if successful would create a Southeast Asian upstream powerhouse. Ophir’s current output of 25,000 boe/d combined with Medco’s stated 2018 target of 85,000 boe/d would take it to 110,000 boe/d, of which 101,000 boe/d is in-region. This would catapult the firm into being the seventh largest non-NOC upstream producer in South-East Asia, above Hess and BP, and just behind Repsol and Total.
“For Medco a successful acquisition would substantially increase its regional footprint and diversify its mature, Indonesia-heavy portfolio. It would also bulk up its non-Asian exposure by adding growth options in Tanzania and Equatorial Guinea, to add to its existing positions in Libya, Oman, Yemen, Tunisia and the US. It would also offer exposure to the global upstream hotspot that is offshore Mexico, where Ophir recently secured participation in three blocks. Following Ophir’s acquisition of Santos’s Asian assets last year it appeared to have pivoted its portfolio towards Asian growth, given its troubled Fortuna FLNG project in Equatorial Guinea was struggling to attract finance.”